EMEA: PRESS RELEASE Q1 2021
Dutch Government Decision on Funding for ME/CFS Research
The European ME Alliance (EMEA) provides a voice for people with Myalgic Encephalomyelitis (ME or ME/CFS) in Europe and is the European partner for facilitating high-quality biomedical research into the disease. EMEA is a grouping of European patient organisations and charities who are involved in supporting patients suffering from ME/CFS and are campaigning for and funding biomedical research to provide treatments and cures.
The Alliance was formed in 2008 by national charities and organisations in Europe.
The Alliance now has representatives from Belgium, Croatia, Czech Republic, Denmark, Finland, France, Germany, Iceland, Ireland, Italy, Netherlands, Norway, Spain, Sweden, Switzerland and the UK – with more planning on joining.
ME/CFS is a debilitating neurological illness classified as such by the World Health Organisation under ICD-10 G93.3.
Our aim is to achieve appropriate funding of biomedical research into ME/CFS to establish an understanding of the aetiology, pathogenesis and epidemiology of the disease. This should lead to the development of treatments and eventually cures for this devastating illness.
Last Update: March 2021